Basic Information
Basic information for NR2F1-AS1-201-12aa
Peptide Name NR2F1-AS1-201-12aa
Genome Position chr5:93411088-93411099,93438718-93438741[-]
Species Human
Peptide Sequence MEFQETFYIHCL
Peptide Length 12
Unique No (NR2F1-AS1-205-12aa,NR2F1-AS1-208-12aa-2,NR2F1-AS1-225-12aa-1,NR2F1-AS1-228-12aa,NR2F1-AS1-230-12aa-1,NR2F1-AS1-231-12aa-1,NR2F1-AS1-235-12aa-1,NR2F1-AS1-236-12aa-2,NR2F1-AS1-239-12aa-1,NR2F1-AS1-252-12aa-1,NR2F1-AS1-255-12aa-1,NR2F1-AS1-257-12aa-1,NR2F1-AS1-259-12aa-1,NR2F1-AS1-267-12aa-1)
Grand Average of Hydropathicity 0.2167
Relative Molecular Mass 1759.01
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000503134;NR2F1-AS1-201
Transcript Length 2035
Coding Ability 0.3946
DNA Sequence Corresponding to Peptide ATGGAATTCCAAGAAACATTCTATATACACTGCCTC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :